Using Light to Fight Drug-Resistant Bacteria
Author Information
Author(s): Bravo Angélica R., Fuentealba Felipe Alejandro, González Iván A., Palavecino Christian Erick
Primary Institution: Universidad Central de Chile
Hypothesis
What is known from the literature about aPDT treatment of multidrug resistance K. pneumoniae infection, either in vitro or in vivo, and how many photosensitizers are used for this purpose?
Conclusion
Antimicrobial photodynamic therapy (aPDT) is effective in eradicating multidrug-resistant Klebsiella pneumoniae strains, but more in vivo research is needed.
Supporting Evidence
- 298 records were found, and after applying eligibility criteria, 25 studies were included.
- Evidence demonstrates the effectiveness of aPDT in vitro in eradicating sensitive or MDR-K. pneumoniae strains.
- MB is the most widely used photosensitizer for aPDT against K. pneumoniae.
Takeaway
Scientists are using special light to help kill superbugs that don't respond to regular medicine, making it easier to treat infections.
Methodology
The study followed PRISMA-ScR guidelines and included original articles from 2012 to 2024 that discussed aPDT against K. pneumoniae.
Limitations
Some articles could not be accessed, and some studies did not show significant clinical relevance.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website